Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.
ESC Heart Fail
; 7(3): 825-834, 2020 06.
Article
in En
| MEDLINE
| ID: mdl-32100468
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fabry Disease
/
Cardiomyopathies
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
ESC Heart Fail
Year:
2020
Document type:
Article
Affiliation country:
Alemania